Diaceutics PLC
DIUXF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $14,564 | $19,838 | $12,320 | $13,775 |
| % Growth | -26.6% | 61% | -10.6% | – |
| Cost of Goods Sold | $2,477 | $2,299 | $3,707 | $2,769 |
| Gross Profit | $12,087 | $17,539 | $8,613 | $11,006 |
| % Margin | 83% | 88.4% | 69.9% | 79.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $15,435 | $16,418 | $0 | $11,911 |
| SG&A Expenses | $15,435 | $16,418 | $12,206 | $11,911 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$169 | -$9 | $0 | $0 |
| Operating Expenses | $15,266 | $16,409 | $12,206 | $11,858 |
| Operating Income | -$3,179 | $1,130 | -$3,593 | -$852 |
| % Margin | -21.8% | 5.7% | -29.2% | -6.2% |
| Other Income/Exp. Net | $166 | $226 | $329 | $369 |
| Pre-Tax Income | -$3,013 | $1,356 | -$3,264 | -$483 |
| Tax Expense | $612 | $475 | -$680 | -$222 |
| Net Income | -$2,401 | $881 | -$2,584 | -$261 |
| % Margin | -16.5% | 4.4% | -21% | -1.9% |
| EPS | -0.028 | 0.01 | -0.031 | -0.003 |
| % Growth | -373.1% | 134% | -887.1% | – |
| EPS Diluted | -0.057 | 0.01 | -0.031 | -0.003 |
| Weighted Avg Shares Out | 42,271 | 84,728 | 84,451 | 84,194 |
| Weighted Avg Shares Out Dil | 84,542 | 84,456 | 84,451 | 84,227 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $226 | $349 | $393 |
| Interest Expense | $0 | $0 | $28 | $24 |
| Depreciation & Amortization | $1,838 | $1,537 | $2,275 | $2,072 |
| EBITDA | -$1,341 | $2,667 | -$961 | $1,571 |
| % Margin | -9.2% | 13.4% | -7.8% | 11.4% |